Boron neutron capture therapy (BNCT) is an effective radiotherapy modality to kill cancer. BNCT can selectively kill cancer cells without damaging the healthy tissue around it by using alpha particle and lithium ion from the reaction of 10B(n,α)7Li. These particles have a track of more or less 5 to 9 μm which is the same as the cell diameter. In order to support the development of BNCT in Indonesia an in vivo simulation is performed in a simple mouse geometry containing a 4T1 breast cancer characteristic treated with BNCT using PHITS program. The Neutron source that was used in this simulation was based on TRIGA Kartini Research Reactor. The boron compound concentration in the tumor was varied from 20 ppm up to 90 ppm, and then the total dose was calculated in the mice. Total dose that the tumor received was 0.0161, 0.0168, 0.0175, 0.0182, 0.0185, 0.0188, 0.019, and 0.0191 Gy-Eq/s, respectively and the irradiation time to reach 50 Gy was 51, 50, 48, 46, 45, 45, 44, 44, 40 minutes respectively. This shows that the higher the concentration of boron compound in the tumor the higher the dose that mice received and irradiation time was decreased with the increase of the boron compound concentration.
INTRODUCTION 
Boron Neutron Capture Therapy (BNCT) is one of the treatments that is developed throughout the world today including in Indonesia. There are many stages in the development of BNCT; one of which is trial on small animals (in vivo). Studies in small animals perform as an approach to human tests for a treatment. BNCT was applied in rats with colorectal liver metastasis using BPA as boron compound, this shows that after a 5-week follow-up there is no liver toxicity detected in the rats (Emilliano et al 2013) . Another BNCT study was perform in a hamster with head and neck cancer, after a 16-week follow-up time no radiotoxicity was observed (Elisa M. Hebera 2014) .  E-mail: ramadhan7valiant@gmail.com BNCT has a promising result in cancer treatment because it can selectively kill cancer cells without giving great damage to the healthy tissue around cancer by use of the alpha particle and ion lithium from the reaction of boron and thermal neutron 10B(n,α)7Li in the body and it is estimated that the particle track of the alpha and ion lithium is the same as cell diameter up to 9 μm (Shinji Kawabata, M.D., et al 2013) . Doses in the BNCT are very different and more complex from doses in other radiotherapy. BNCT has four components of doses which are doses from photon absorbed dose, fast neutron absorbed dose, nitrogen absorbed dose, and boron absorbed dose (Carl Ostlund 2005) . There are 2 types of common boron compound that are used in BNCT which is BSH and BPA. Optimizing BNCT treatment can be done by improving the delivery of the boron carrier to the tumor (V. A. . Selectivity of BNCT to cancer treatment is affected by ration of boron concentration in tumor and healthy tissue (Yoshiaki Yura, 2012) .
In order to support a planning for experiments on BNCT, simulation was performed. Dosimetric efficacy of BNCT in liver metastases and liver cancer are investigated by simulation using MCNP and it shows that simulation using MCNP has potential (M. Blaickner, 2011) . Another program used to simulate BNCT is PHITS, which can simulate a full-body phantom doses resulting from irradiation in BNCT treatment (Kenta Takada 2014) and also simulate an absorbed dose and neutron energy spectra resulting from accelerator (Monika Puchalska 2015) .
In this study we simulated in vivo trial use PHITS program developed by Japan Atomic Energy Agency and calculated the total dose of each boron concentration that varies from 20 ppm up to 90 ppm. We used simple ellipsoid geometry as a mice body and a simple spherical geometry in the mice body as a tumor. The goal of this study is to support, provide data and reference for an experiment in the in vivo test in TRIGA Kartini Reactor. The Boron compound that was used in this study is BSH.
MATERIALS AND METHODS

Neutron Source and in vivo test facility design
This simulation used a neutron source based on characteristic thermal column TRIGA Kartini Research Reactor in Indonesia. We used a collimator design based on the previous study in simulation using MCNP to design a collimator for BNCT trial in thermal column TRIGA Kartini Reactor (M.Ilma Muslih Arrozaqi 2014). Neutron flux that came out from the aperture of the collimator in the simulation is 5.56 × 10 8 . This result is still proper for BNCT trial. Small animals were put in a box as an in vivo facility with a volume 30 × 30 × 30 cm 3 that was made from Al ( Figure. 
Animal Model
We created simple ellipsoid geometry as a mice body consists with cancer in a form of a small spherical geometry inside the ellipsoid. We use 4T1 breast cancer in this study, in 5th week the tumor growth has reached a volume of 1000 mm 3 (Bailey-Downs LC 2014). (ICRU 1989) . Figure 2 shows the geometry of the animal model. 
Evaluating Total Dose in Mice
Simulation using PHITS program (Particle and Heavy Ion Transport Code System) developed by Japan Atomic Energy Agency, we use two calculation mode; first based on tally [T-Deposit] in PHITS program, and second using kerma factor conversion as a multiplier in PHITS from flux to dose. The physical absorbed doses from the simulation convert to photon equivalent doses by multiplying each component of doses with the weighted factor (Minoru Suzuki 2014). In this simulation we vary the boron concentration in tumor which is 20 ppm, 30 ppm, 40 ppm, 50 ppm, 60 ppm, 70 ppm, 80 ppm, and 90 ppm. Volume of the tumor is the same for every boron concentration that is 1 mm 3 , and also mice and irradiation position is the same.
RESULTS AND DISCUSSION
Neutron flux distribution that came out in the aperture of the collimator by using PHITS program is 5. 941 × 10 8 Figure. 3 this result is not very far from the previous study where neutron flux that came out in the aperture using MCNP simulation was 5.56 × 10 8 (Ilma Muslih Arrozaqi 2014). This result of neutron flux is still proper to use in the BNCT trial. In the previous study reactor criticality simulation with MCNP performed in order to get neutron output from the TRIGA Kartini reactor core, but in this PHITS simulation reactor criticality is not performed. We take the neutron spectrum output from the reactor core in MCNP simulation and use it as source input in our PHITS simulation. With the change of the boron concentration in the tumor boron absorbed doses increased, while the proton absorbed dose decreased. The neutron absorbed dose and the photon absorbed dose also change but only in a small fraction. Increasing of boron absorbed dose with the increasing of the boron concentration is due to the boron concentration in the tumor that increased. With this increased concentration the producing of alpha particle and lithium ion in the tumor becomes higher. Table. 2 shows the total weighted dose that has been multiplied with the weighting factor of each component dose (Wolfgang 2012) in mice tumor. It also shows the irradiation time needed to reach dose 50 Gy-eq. With the increasing boron concentration in tumor the irradiation time becomes shorter. This is because high boron concentration produces more alpha and lithium ion. This result of irradiation times for in vivo simulation if compared to the previous study that using MCNP to simulate in vivo trial of BNCT (Adrian T. 2016) is more or less two times shorter. This is because in this simulation we did not define the GTV, CTV, and PTV and the mice geometry simpler than before. 
CONCLUSION AND REMARKS
We have studied the simulation of BNCT in vivo trial based on the TRIGA Kartini Research Reactor using PHITS. We evaluated the total dose and the irradiation time needed to reach 50 Gy-eq while we vary the boron concentration in mice tumor. We found that with the increasing of boron concentration in mice the total dose also increases and the irradiation time becomes shorter.
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